GSK3beta  (1015) Citations (4)

Originally described in: GSK3beta phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.
Lang UE, Kocabayoglu P, Cheng GZ, Ghiassi-Nejad Z, Munoz U, Vetter D, Eckstein DA, Hannivoort RA, Walsh MJ, Friedman SL Oncogene. 2012 Oct 22. doi: 10.1038/onc.2012.457. PubMed Journal

---

Articles Citing GSK3beta  (1015)

Articles
TFAP2 transcription factors are regulators of lipid droplet biogenesis. Scott CC, Vossio S, Rougemont J, Gruenberg J. Elife. 2018 Sep 26;7. pii: 36330. doi: 10.7554/eLife.36330. PubMed
Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non-small cell lung cancer. Dimou A, Nasarre C, Peterson YK, Pagano R, Gooz M, Nasarre P, Drabkin HA, Armeson KE, Gibney BC, Gemmill RM, Denlinger CE. J Thorac Cardiovasc Surg. 2020 May 25. pii: S0022-5223(20)31233-2. doi: 10.1016/j.jtcvs.2020.03.166. PubMed
Glycogen Synthase Kinase 3 Beta Regulates the Human Aryl Hydrocarbon Receptor Cellular Content and Activity. Yang Y, Chan WK. Int J Mol Sci. 2021 Jun 5;22(11). pii: ijms22116097. doi: 10.3390/ijms22116097. PubMed
PP2A B55alpha inhibits epithelial-mesenchymal transition via regulation of Slug expression in non-small cell lung cancer. Singh D, Qiu Z, Jonathan SM, Fa P, Thomas H, Prasad CB, Cai S, Wang JJ, Yan C, Zhang X, Venere M, Li Z, Sizemore ST, Wang QE, Zhang J. Cancer Lett. 2024 Aug 28;598:217110. doi: 10.1016/j.canlet.2024.217110. Epub 2024 Jul 8. PubMed

If you have published an article using this material, please email us at to have your article added to this page.